For these reasons, increasing the expression of CX3CL1 and CX3CR1 in the tumor simultaneously improves the prognosis of patients with cancers such as colorectal cancer [79] and hepatocellular carcinoma [109]. This evidence concerns the gene CX3CR1 and hepatocellular carcinoma.